bergamottin and Acute-Lung-Injury

bergamottin has been researched along with Acute-Lung-Injury* in 1 studies

Other Studies

1 other study(ies) available for bergamottin and Acute-Lung-Injury

ArticleYear
Bergamottin alleviates LPS-induced acute lung injury by inducing SIRT1 and suppressing NF-κB.
    Innate immunity, 2021, Volume: 27, Issue:7-8

    Acute lung injury (ALI) is associated with a high mortality due to inflammatory cell infiltration and lung edema. The development of ALI commonly involves the activation of NF-κB. Since bergamottin is a natural furanocoumarin showing the ability to inhibit the activation of NF-κB, in this study we aimed to determine the effect of bergamottin on ALI. RAW264.7 mouse macrophages were pre-treated with bergamottin and then stimulated with LPS. Macrophage inflammatory responses were examined. Bergamottin (50 mg/kg body mass) was intraperitoneally administrated to mice 12 h before injection of LPS, and the effect of bergamottin on LPS-induced ALI was evaluated. Our results showed that LPS exposure led to increased production of TNF-α, IL-6, and monocyte chemoattractant protein-1 (MCP-1), which was impaired by bergamottin pre-treatment.

    Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Cytokines; Furocoumarins; Lipopolysaccharides; Lung; Mice; NF-kappa B; Sirtuin 1

2021